A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Evaluate the Safety and Efficacy of Pitolisant in Adult Patients With Idiopathic Hypersomnia
Condition: Idiopathic Hypersomnia Interventions: Drug: Pitolisant Oral Tablet; Drug: Placebo oral tablet Sponsor: Harmony Biosciences, LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 14, 2021 Category: Research Source Type: clinical trials
Idiopathic Hypersomnia
Condition: Hypersomnia, Idiopathic Intervention: Other: Polysomnography Sponsor: Uppsala University Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 9, 2021 Category: Research Source Type: clinical trials